Authors: GOODKIN DE RUDICK RA MEDENDORP SVB DAUGHTRY MM VANDYKE C

Citation: De. Goodkin et al., LOW-DOSE ORAL METHOTREXATE IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS - ANALYSES OF SERIAL MRIS, Neurology, 47(5), 1996, pp. 1153-1157

Authors: GOODKIN DE RUDICK RA MEDENDORP SV DAUGHTRY MM SCHWETZ KM FISCHER J VANDYKE C

Citation: De. Goodkin et al., LOW-DOSE (7.5-MG) ORAL METHOTREXATE REDUCES THE RATE OF PROGRESSION IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS, Annals of neurology, 37(1), 1995, pp. 30-40

Authors: FISCHER JS GOODKIN DE RUDICK RA PERKINS KK BARILLA DY DAUGHTRY MM SCHWETZ KM MEDENDORP SV

Citation: Js. Fischer et al., LOW-DOSE (7.5 MG) ORAL METHOTREXATE IMPROVES NEUROPSYCHOLOGICAL FUNCTION IN PATIENTS WITH CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS, Annals of neurology, 36(2), 1994, pp. 289-289

Authors: GOODKIN DE RUDICK RA MEDENDORP SV DAUGHTRY MM SCHWETZ K

Citation: De. Goodkin et al., LOW-DOSE ORAL WEEKLY METHOTREXATE (MTX) SIGNIFICANTLY REDUCES THE FREQUENCY OF PROGRESSION OF IMPAIRMENT IN PATIENTS WITH CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS (CPMS), Neurology, 44(4), 1994, pp. 10000357-10000357